Flegafortan, 1.6 mg/ml Flegafrotan_główne

Flegafortan, 1.6 mg/ml

Flegafortan syrup is indicated to treat chronic airway diseases with difficult expectoration (coughing up) of thick bronchial secretions (mucus). Flegafortan contains an active ingredient which:

  • thins the mucus
  • clears bronchial passages
  • facilitates expectoration
Flegafortan syrup contains 1.6mg/mL bromohexine hydrochloride (active ingredient) which is the highest concentration in syrups available on the market.*

*Sales data for 06.2017–05.2018 according to PEX

Pharmaceutical form Syrup. 200 ml

Category OTC

Active substance

1.6 mg/mL bromohexine hydrochloride


Chronic and acute airway diseases with difficult expectoration of thick bronchial secretions.


- Allergy to the active ingredient or any of the other components of the product.
- Flegafortan should not be used in children under 6 years of age.
- Do not use Flegafortan in patients with gastric and duodenal ulcers.

Marketing Authorisation Holder

Aflofarm Farmacja Polska Spółka z o.o.

Marketing Authorisation


Information for the patient

Read the package leaflet for indications, contraindications, side effects, dosage as well as information on the use of this product, or consult your doctor or pharmacist before use. Misusing medicines may be dangerous to your life or health.

See how we care about quality

All our products are subject to strict safety requirements

We use rigorous quality control standards and procedures to ensure the highest level of safety for all our products.

See how we care about safety